Chemed Corp (NYSE: CHE)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0000019584
Market Cap 6.38 Bn
P/B 5.92
P/E 22.87
P/S 2.52
ROIC (Qtr) 21.09
Div Yield % 0.62
Rev 1y % (Qtr) 3.09
Total Debt (Qtr) 141.47 Mn
Debt/Equity (Qtr) 0.13

About

Chemed Corporation, known as CHEMED, operates in the healthcare industry with two primary segments: VITAS and Roto-Rooter. The VITAS segment focuses on hospice and palliative care services, while Roto-Rooter provides plumbing and drain cleaning services. With its headquarters in the United States, Chemed offers its services domestically and in over 40 states. CHEMED's VITAS segment is a prominent player in the hospice care industry, providing comfort and support for patients with terminal illnesses and their families. Through a network of physicians,...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 419.65M provides robust 2.97x coverage of total debt 141.47M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 129.75M provide 3.09x coverage of short-term debt 42.01M, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 871.70M provides 6.16x coverage of total debt 141.47M, indicating robust asset backing and low credit risk.
  • Operating cash flow of 419.65M provides strong 10.89x coverage of stock compensation 38.54M, indicating sustainable incentive practices.
  • Operating cash flow of 419.65M provides exceptional 242.85x coverage of interest expenses 1.73M, showing strong debt service capability.

Bear case

  • Operating cash flow of 419.65M barely covers its investment activities of (55.91M), with a coverage ratio of -7.51, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of 419.65M provides thin coverage of dividend payments of (30.69M) with a -13.67 ratio, suggesting potential dividend sustainability issues if operational performance deteriorates.
  • Cash reserves of 129.75M provide limited coverage of acquisition spending of (225000), which is -576.68x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • High receivables of 215.57M relative to inventory of 8.24M (26.17 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Operating cash flow of 419.65M is outpaced by equity issuance of (432.52M) (-0.97 ratio), indicating concerning reliance on equity markets for funding operations.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 3.84 1.26
EV to Cash from Ops. EV/CFO 14.86 12.78
EV to Debt EV to Debt 44.07 12.10
EV to EBIT EV/EBIT 16.75 10.74
EV to EBITDA EV/EBITDA 14.99 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 17.11 18.02
EV to Market Cap EV to Market Cap 0.98 432.64
EV to Revenue EV/Rev 2.46 2.77
Price to Book Value [P/B] P/B 5.89 -1.92
Price to Earnings [P/E] P/E 22.74 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 9.08 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 11.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 2.10 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 8.29 5.42
Interest Coverage Int. cover (Qtr) 215.38 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -21.71 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) -45.59 65.22
Dividend Growth (1y) % Div 1y % (Qtr) 23.53 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -7.55 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -2.57 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -6.15 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -6.20 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) -4.90 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 15.41 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) -1.85 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.56 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.06 0.04
Cash Ratio Cash Ratio (Qtr) 0.44 0.39
Current Ratio Curr Ratio (Qtr) 1.35 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.13 -13.19
Interest Cover Ratio Int Coverage (Qtr) 215.38 -97.94
Times Interest Earned Times Interest Earned (Qtr) 215.38 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 17.20 -95.81
EBIT Margin % EBIT Margin % (Qtr) 14.71 -94.97
EBT Margin % EBT Margin % (Qtr) 14.64 -105.60
Gross Margin % Gross Margin % (Qtr) 32.90 23.31
Net Profit Margin % Net Margin % (Qtr) 11.00 -106.14